Tengion Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Cost of Goods Sold (COGS) incl. D&A
4,937.10
4,861.90
3,141.00
456.00
267.00
Gross Income
4,937.10
4,861.90
3,141.00
456.00
267.00
SG&A Expense
23,474.90
18,887.50
19,668.00
15,599.00
15,775.00
EBIT
28,412.00
23,749.40
23,614.00
16,220.00
16,597.00
Unusual Expense
-
191.50
5,349.00
2,221.00
5,245.00
Interest Expense
1,644.10
2,104.50
849.00
2,957.00
7,622.00
Pretax Income
29,845.00
25,600.30
19,061.00
16,929.00
18,927.00
Consolidated Net Income
29,845.00
25,600.30
19,061.00
16,929.00
18,927.00
Net Income
29,845.00
25,600.30
19,061.00
16,929.00
18,927.00
Net Income After Extraordinaries
29,845.00
25,600.30
19,061.00
16,929.00
18,927.00
Net Income Available to Common
43,904.30
29,592.90
19,061.00
16,929.00
18,927.00
EPS (Basic)
69.15
32.20
8.80
7.13
4.70
Basic Shares Outstanding
634.90
919.70
2,162.90
2,374.00
4,024.00
EPS (Diluted)
69.15
32.18
8.81
7.13
4.70
Diluted Shares Outstanding
634.90
919.70
2,162.90
2,374.00
4,024.00
EBITDA
23,474.90
18,887.50
20,473.00
15,764.00
16,330.00
Other Operating Expense
-
-
805.00
165.00
555.00
Non-Operating Interest Income
211.00
62.20
53.00
27.00
47.00
Preferred Dividends
14,059.30
3,992.60
-
-
-

About Tengion

View Profile
Address
3929 Westpoint Boulevard
Winston-Salem North Carolina 27103
United States
Employees -
Website http://www.tengion.com
Updated 07/08/2019
Tengion, Inc. is a regenerative medicine company, focused on discovering, developing, manufacturing and commercializing of neo-organs and products. Tengion was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.